small molecule

CETYLEV

ACETYLCYSTEINE

Loss of exclusivityMay 2032latest FDA-listed patent expiry
CompanyARBOR PHARMACEUTICALS LLC

Drug detail

Brand nameCETYLEV
Active ingredientACETYLCYSTEINE
Strength2.5GM
Dosage formTABLET, EFFERVESCENT
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2016
Marketing statusDISCN

Listed patents

PatentExpiresType
9561204May 2032use U-1373
8747894May 2032product
9427421May 2032product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

CETYLEV patent cliff — loss of exclusivity May 2032 | CliffBio